FDA Drug Recalls
17,898 recalls, newest first
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 6, 2020
Reason Lack of Processing Control
Class II · Moderate risk Terminated Apr 3, 2020
Reason CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.